Acceptability

可接受性
  • 文章类型: Systematic Review
    背景:移动技术越来越多地用于医疗保健和公共卫生实践中,用于患者沟通,监测,和教育。移动健康(mHealth)工具也已用于促进坚持慢性肌肉骨骼疼痛(CMP)管理,这对实现改善疼痛结果至关重要,生活质量,和具有成本效益的医疗保健。
    目的:本系统综述的目的是评估有关依从性的文献的25年趋势,可用性,可行性,以及患者和医疗保健提供者在CMP管理中的mHealth干预措施的可接受性。
    方法:我们搜索了PubMed,科克伦中部,MEDLINE,EMBASE,和WebofScience数据库,用于评估1999年1月至2023年12月mHealth在CMP管理中的作用的研究。感兴趣的结果包括mHealth干预对患者依从性的影响;干预后疼痛特异性临床结果;和可用性,可行性,以及目标最终用户在慢性疼痛管理中mHealth工具和平台的可接受性。
    结果:共89篇(26,429名参与者)纳入系统评价。在纳入的研究中,移动应用程序是最常用的mHealth工具(78/89,88%)。其次是移动应用程序加显示器(5/89,6%),移动应用程序加可穿戴传感器(4/89,4%),和基于网络的移动应用程序加显示器(1/89,1%)。可用性,可行性,在26%(23/89)的研究中评估了mHealth干预措施的可接受性或患者偏好,并观察到总体较高.总的来说,30%(27/89)的研究使用随机对照试验(RCT),队列,或试点设计,以评估m健康干预对患者依从性的影响,在93%(25/27)的这些研究中观察到显著改善(所有P<0.05)。在测量mHealth对CMP特异性临床结果的影响的29个RCT中,有27个(93%)报告了组间差异的显着(在P<0.05时判断)。
    结论:mHealth工具有很大的潜力来更好地促进对CMP管理的坚持,目前支持其有效性的证据普遍很高。进一步的研究应集中在mHealth干预措施的成本效益上,以更好地将这些工具纳入医疗保健实践。
    背景:国际前瞻性系统审查注册(PROSPERO)CRD42024524634;https://www.crd.约克。AC.uk/prospro/display_record.php?RecordID=524634。
    BACKGROUND: Mobile technologies are increasingly being used in health care and public health practice for patient communication, monitoring, and education. Mobile health (mHealth) tools have also been used to facilitate adherence to chronic musculoskeletal pain (CMP) management, which is critical to achieving improved pain outcomes, quality of life, and cost-effective health care.
    OBJECTIVE: The aim of this systematic review was to evaluate the 25-year trend of the literature on the adherence, usability, feasibility, and acceptability of mHealth interventions in CMP management among patients and health care providers.
    METHODS: We searched the PubMed, Cochrane CENTRAL, MEDLINE, EMBASE, and Web of Science databases for studies assessing the role of mHealth in CMP management from January 1999 to December 2023. Outcomes of interest included the effect of mHealth interventions on patient adherence; pain-specific clinical outcomes after the intervention; and the usability, feasibility, and acceptability of mHealth tools and platforms in chronic pain management among target end users.
    RESULTS: A total of 89 articles (26,429 participants) were included in the systematic review. Mobile apps were the most commonly used mHealth tools (78/89, 88%) among the included studies, followed by mobile app plus monitor (5/89, 6%), mobile app plus wearable sensor (4/89, 4%), and web-based mobile app plus monitor (1/89, 1%). Usability, feasibility, and acceptability or patient preferences for mHealth interventions were assessed in 26% (23/89) of the studies and observed to be generally high. Overall, 30% (27/89) of the studies used a randomized controlled trial (RCT), cohort, or pilot design to assess the impact of the mHealth intervention on patients\' adherence, with significant improvements (all P<.05) observed in 93% (25/27) of these studies. Significant (judged at P<.05) between-group differences were reported in 27 of the 29 (93%) RCTs that measured the effect of mHealth on CMP-specific clinical outcomes.
    CONCLUSIONS: There is great potential for mHealth tools to better facilitate adherence to CMP management, and the current evidence supporting their effectiveness is generally high. Further research should focus on the cost-effectiveness of mHealth interventions for better incorporating these tools into health care practices.
    BACKGROUND: International Prospective Register of Systematic Reviews (PROSPERO) CRD42024524634; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=524634.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    妊娠期糖尿病(GDM)会增加母婴不良结局的风险。预防性干预可以有效地帮助患有GDM的孕妇。目前,孕妇不知道预防GDM的重要性,他们的自我管理能力很低。最近,mHealth技术已在全球范围内使用。因此,开发用于GDM预防的移动健康应用程序可能会帮助孕妇降低GDM的风险。
    要设计和开发移动应用程序,评估其接受度,并了解用户的使用经验和建议,从而为有GDM风险的孕妇提高自我管理能力和预防GDM提供了有效的工具。
    使用以用户为中心的设计方法开发了一种基于证据的GDM预防应用程序(更好的怀孕),遵循健康信念模式,并纳入GDM风险预测。2022年6月至8月,采用了一种方便的抽样方法,选择了102名有GDM风险的孕妇进行试点研究。一周后,应用程序的可接受性是使用申请接受问卷进行评估的,我们根据女性的反馈更新了应用程序。我们使用SPSS26.0进行数据分析。
    该应用程序提供各种功能,包括GDM风险预测,健康管理计划,行为管理,健康信息,个性化的指导和咨询,同行支持,家庭支持,和其他功能。总的来说,102名孕妇同意参加这项研究,达到98%的保留率;然而,2%(n=2)退出。更好的怀孕应用程序的平均可接受性评分为5分的4.07。此外,与会者提出了一些旨在加强应用的建议。
    本研究开发的更好的怀孕应用程序可以作为预防GDM的辅助管理工具,为后续随机对照试验提供基础。
    UNASSIGNED: Gestational diabetes mellitus (GDM) can increase the risk of adverse outcomes for both mothers and infants. Preventive interventions can effectively assist pregnant women suffering from GDM. At present, pregnant women are unaware of the importance of preventing GDM, and they possess a low level of self-management ability. Recently, mHealth technology has been used worldwide. Therefore, developing a mobile health app for GDM prevention could potentially help pregnant women reduce the risk of GDM.
    UNASSIGNED: To design and develop a mobile application, evaluate its acceptance, and understand the users\'using experience and suggestions, thus providing a valid tool to assist pregnant women at risk of GDM in enhancing their self-management ability and preventing GDM.
    UNASSIGNED: An evidence-based GDM prevent app (Better pregnancy) was developed using user-centered design methods, following the health belief model, and incorporating GDM risk prediction. A convenient sampling method was employed from June to August 2022 to select 102 pregnant women at risk of GDM for the pilot study. After a week, the app\'s acceptability was evaluated using an application acceptance questionnaire, and we updated the app based on the feedback from the women. We used SPSS 26.0 for data analysis.
    UNASSIGNED: The application offers various functionalities, including GDM risk prediction, health management plan, behavior management, health information, personalized guidance and consultation, peer support, family support, and other functions. In total, 102 pregnant women consented to participate in the study, achieving a retention rate of 98%; however, 2% (n = 2) withdrew. The Better pregnancy app\'s average acceptability score is 4.07 out of 5. Additionally, participants offered several suggestions aimed at enhancing the application.
    UNASSIGNED: The Better pregnancy app developed in this study can serve as an auxiliary management tool for the prevention of GDM, providing a foundation for subsequent randomized controlled trials.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:癌前病变和宫颈癌的主要筛查技术是人乳头瘤病毒(HPV)检测,和HPV自我取样已被证明在结果的准确性方面与临床医生取样一致,并可能提高宫颈癌筛查率.这项研究的目的是了解意识水平,经验,可接受性,江苏女性对阴道HPV自我取样的偏好,浙江,上海,中国,并分析可能的影响因素,确定实施自抽样的可行性。
    方法:总的来说,1793名妇女被纳入数据分析。使用了自我管理的问卷。除了描述性分析,单变量和多变量分析用于探索社会人口统计学特征之间的关联,宫颈癌筛查史,和意识水平,经验,可接受性,以及对HPV自身样本的偏好。
    结果:参与者对HPV自我取样的认识和经验水平中等。共有88.8%的参与者将可接受性评为“高”,64.2%的人首选自我抽样进行宫颈癌筛查。年龄在45至54岁之间的人表现出对临床医生采样(OR=1.762(1.116-2.163))和自我采样(OR=1.823(1.233-2.697))的偏好。高中以上毕业者(OR=2.305(1.517-3.503),OR=2.432(1.570-3.768),OR=3.258(2.024-5.244))首选临床医生抽样,本科及以上学历者(OR=1.664(1.042-2.657))首选自我抽样。中等收入和高收入个人对这两种抽样方法都没有偏好(OR<1)。
    结论:HPV自采样已被广泛接受,但是意识,经验和偏好需要改进。这些结果可能有助于调整公共卫生策略,以便在预防宫颈癌的国家举措中尽早纳入HPV自采样作为筛查方法。
    BACKGROUND: The primary screening technique for precancerous lesions and cervical cancer is human papillomavirus (HPV) testing, and HPV self-sampling has been shown to be consistent with clinician sampling in terms of the accuracy of the results and may improve cervical cancer screening rates. The aim of this study was to understand the level of awareness, experience, acceptability, and preference for vaginal HPV self-sampling among women in Jiangsu, Zhejiang, and Shanghai, China, and to analyze the possible influencing factors to determine the feasibility of implementing self-sampling.
    METHODS: Overall, 1793 women were included in the data analysis. A self-administered questionnaire was utilized. In addition to descriptive analysis, univariate and multivariate analyses were used to explore the associations between sociodemographic features, history of cervical cancer screening, and the level of awareness, experience, acceptability, and preference for HPV self-samples.
    RESULTS: The participants\' level of awareness of and experience with HPV self-sampling were moderate. A total of 88.8% of participants rated the acceptability as \"high\", and self-sampling was preferred by 64.2% of them for cervical cancer screening. People aged 45 to 54 years showed a preference for both clinician sampling(OR = 1.762 (1.116-2.163)) and self-sampling (OR = 1.823 (1.233-2.697)). Those who had graduated from high school or above (OR = 2.305 (1.517-3.503), OR = 2.432 (1.570-3.768), OR = 3.258 (2.024-5.244)) preferred clinician-sampling, and those with a bachelor\'s degree or above (OR = 1.664 (1.042-2.657)) preferred self-sampling. Middle- and high-income individuals showed no preference for either sampling method (OR < 1).
    CONCLUSIONS: HPV self-sampling is widely accepted, but awareness, experience and preferences need to be improved. These results may help to adjust public health strategies for the early inclusion of HPV self-sampling as a screening method in national initiatives to prevent cervical cancer.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    抗炎药已成为重度抑郁症(MDD)的潜在新疗法。在这个荟萃分析中,我们的目的是评估抗炎药的抗抑郁作用并比较其疗效.
    我们对多个数据库进行了全面搜索,包括PubMed,Embase,WebofScience,Cochrane评论,Cochrane审判,和ClinicalTrials.gov,确定合格的随机临床试验。我们的荟萃分析的主要结局指标是疗效和可接受性,而次要结局指标集中在缓解率和不良事件导致的脱落率.我们使用比值比(OR)和95%置信区间(95%CI)来呈现我们的结果。
    共48项研究纳入我们的分析。就功效而言,与安慰剂相比,抗炎药显示出显著的抗抑郁作用(OR=2.04,95%CI:1.41-2.97,p=0.0002).亚组分析显示,在辅助治疗亚组(OR=2.17,95%CI:1.39-3.37,p=0.0006)和无难治性抑郁症亚组的MDD患者中,抗炎药也表现出明显的抗抑郁作用(OR=2.33,95%CI:1.53-3.54,p<0.0001)。基于曲面下累积排序曲线(SUCRA)值的网络荟萃分析,非甾体抗炎药(NSAIDs)(SUCRA值=81.6)在所包括的抗炎药中表现出最高的可接受性.
    总之,我们的荟萃分析表明,抗炎药具有显著的抗抑郁作用,并且被广泛接受.此外,抗炎药的辅助治疗被证明可有效治疗MDD。在评估的抗炎药中,NSAIDs表现出最高的可接受性,尽管其疗效与安慰剂相当。
    https://www.crd.约克。AC.uk/prospro/display_record.php?RecordID=422004),标识符CRD42023422004。
    UNASSIGNED: Anti-inflammatory agents have emerged as a potential new therapy for major depressive disorder (MDD). In this meta-analysis, our aim was to evaluate the antidepressant effect of anti-inflammatory agents and compare their efficacy.
    UNASSIGNED: We conducted a comprehensive search across multiple databases, including PubMed, Embase, Web of Science, Cochrane Review, Cochrane Trial, and ClinicalTrials.gov, to identify eligible randomized clinical trials. The primary outcome measures of our meta-analysis were efficacy and acceptability, while the secondary outcome measures focused on remission rate and dropout rate due to adverse events. We used odds ratio (OR) and 95% confidence interval (95% CI) to present our results.
    UNASSIGNED: A total of 48 studies were included in our analysis. In terms of efficacy, anti-inflammatory agents demonstrated a significant antidepressant effect compared to placebo (OR = 2.04, 95% CI: 1.41-2.97, p = 0.0002). Subgroup analyses revealed that anti-inflammatory agents also exhibited significant antidepressant effects in the adjunctive therapy subgroup (OR = 2.17, 95% CI: 1.39-3.37, p = 0.0006) and in MDD patients without treatment-resistant depression subgroup (OR = 2.33, 95% CI: 1.53-3.54, p < 0.0001). Based on the surface under the cumulative ranking curve (SUCRA) value of network meta-analysis, nonsteroidal anti-inflammatory drugs (NSAIDs) (SUCRA value = 81.6) demonstrated the highest acceptability among the included anti-inflammatory agents.
    UNASSIGNED: In summary, our meta-analysis demonstrates that anti-inflammatory agents have significant antidepressant effects and are well-accepted. Furthermore, adjunctive therapy with anti-inflammatory agents proved effective in treating MDD. Among the evaluated anti-inflammatory agents, NSAIDs exhibited the highest acceptability, although its efficacy is comparable to placebo.
    UNASSIGNED: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=422004), identifier CRD42023422004.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:构建6~23月龄婴幼儿的辅食质地,观察不同月龄婴儿对辅食的可接受性。
    方法:根据国内外指南,关于补充喂养的共识和文献,并结合我国儿童生长发育的特点。构建了6-23月龄婴幼儿的辅食质构指数。南部和北部分别选择了一个省,每个省选择一个城市和一个农村地区作为观察点。各观测点采用分层随机抽样原则,选择240名婴幼儿进行可接受性研究。根据食物种类,选择了12种常见食品作为补充食品工具包。指示父母根据相应的月龄在家中制作辅食,观察并记录单/混合辅食喂养的可接受性。
    结果:6个月的辅食质地指数,7-8个月,9-11个月,12-17个月,建造了18-23个月。护理人员可以根据建立的补充食物质地指数在相应的月龄制作补充食物。6-23个月婴幼儿对单一辅食的接受度为98.3%,98.7%,99.8%,96.9%和97.5%,分别。7-23个月儿童对混合辅食的接受度为98.3%,99.6%,93.8%和97.5%,分别。
    结论:不同月龄的辅食质地指标可以在家中制作,不同质地的可接受性较好。
    OBJECTIVE: To construct the complementary food texture in infants and young children aged 6 to 23 months, and observe the acceptability of complementary food of different months old infants.
    METHODS: Based on the domestic and foreign guidelines, consensus and literatures on complementary feeding, and combined with the characteristics of children's growth and development in China. The complementary food texture index of 6-23 months old infants and young children was constructed. One province was selected in the south and north respectively, one city and one rural area was selected as the observation point in each province. The stratified random sampling principle was adopted in each observation point, 240 infants and young children were selected for the acceptability study. According to the food type, 12 common foods were selected to make the complementary food toolkit. The parents were instructed to make complementary food at home according to the corresponding month age, observe and record the acceptability of single/mixed complementary food feeding.
    RESULTS: The complementary food texture index of 6 months, 7-8 months, 9-11 months, 12-17 months, 18-23 months was constructed. Caregivers could make complementary food at the corresponding month age according to the established complementary food texture index. The acceptability of single complementary food for infants and young children aged 6-23 months was 98.3%, 98.7%, 99.8%, 96.9% and 97.5%, respectively. The acceptability of mixed complementary food for children aged 7-23 months was 98.3%, 99.6%, 93.8% and 97.5%, respectively.
    CONCLUSIONS: The complementary food texture index of different month age can be made at home, and the acceptability of different texture is good.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    背景:音乐疗法在随机对照试验(RCT)中得到了越来越多的研究,并显示出治疗创伤后应激障碍(PTSD)的潜力。目的:本系统综述和荟萃分析批判性地评估了当前支持音乐疗法对PTSD的疗效和可接受性的临床证据。方法:从主要的英语和中文数据库中检索RCT,比较除常规护理外的音乐疗法(CAU)与单独的CAU或CAU联合标准心理治疗/药物治疗的PTSD。计算治疗后PTSD症状评分的标准化平均差异(SMD)和治疗完成后保留率的风险差异(RD),以评估音乐疗法的疗效和可接受性。分别。Cochrane偏差风险(RoB)工具2.0和建议分级,评估,发展,和评估(等级)用于评估纳入研究的RoB和证据的确定性,分别。结果:九项研究,纳入527名PTSD患者,包括在内,所有与高RoB。音乐疗法组治疗后PTSD症状评分明显低于非活动对照组(SMD=-1.64,P<.001),但音乐疗法组与主动对照组之间具有可比性(SMD=-0.28,P=.330)。音乐疗法组和两个对照组的保留率没有显着差异(RD=0.03,P=.769;RD=0.16,P=.829)。等级将证据的确定性等级评为较低。结论:尽管荟萃分析结果表明,音乐疗法可有效减轻创伤后应激障碍患者的创伤后症状,其治疗效果与标准心理治疗相当,低水平的确定性限制了它的普遍性。需要进行更严格的方法学研究,以加强音乐疗法对PTSD的疗效和可接受性的临床证据。
    这篇系统综述批判性地评估了音乐疗法对创伤后应激障碍(PTSD)的有效性和可接受性的现有方法上严格的证据。音乐疗法组的治疗后PTSD症状评分明显低于非活动对照组,音乐疗法组与活动对照组之间具有可比性。音乐疗法组与非活动和活动对照组之间的治疗后保留率没有显着差异。
    Background: Music therapy is increasingly examined in randomized controlled trials (RCTs) and shows potential in treating post-traumatic stress disorder (PTSD).Objective: This systematic review and meta-analysis critically evaluates the current clinical evidence supporting the efficacy and acceptability of music therapy for PTSD.Method: RCTs comparing music therapy in addition to care as usual (CAU) versus either CAU alone or CAU combined with standard psychotherapy/pharmacotherapy for PTSD were retrieved from major English - and Chinese-language databases. Standardized mean differences (SMDs) for post-treatment PTSD symptom scores and risk differences (RDs) for retention rates upon treatment completion were calculated to assess the efficacy and acceptability of music therapy, respectively. The Cochrane risk of bias (RoB) tool 2.0 and the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) were used to assess the RoB of included studies and certainty of the evidence, respectively.Results: Nine studies, incorporating 527 PTSD patients, were included, all with high RoB. The post-treatment PTSD symptom scores were significantly lower in the music therapy group than the inactive control group (SMD = -1.64, P < .001), but comparable between the music therapy group and the active control group (SMD = -0.28, P = .330). The retention rates did not differ significantly between the music therapy group and both control groups (RD = 0.03, P = .769; RD = 0.16, P = .829). The GRADE rated certainty level of evidence as low.Conclusions: Although meta-analytic findings suggest that music therapy is effective in reducing post-traumatic symptoms in individuals with PTSD, with its therapeutic effect comparable to that of standard psychotherapy, the low level of certainty limits its generalizability. More methodologically stringent studies are warranted to strengthen the clinical evidence for the efficacy and acceptability of music therapy for PTSD.
    This systematic review critically appraised the existing methodologically rigorous evidence for the efficacy and acceptability of music therapy for post-traumatic stress disorder (PTSD).The post-treatment PTSD symptom scores were significantly lower in the music therapy group than the inactive control group and comparable between the music therapy group and the active control group.The post-treatment retention rates did not differ significantly between the music therapy group and both the inactive and active control groups.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Systematic Review
    背景:益生菌给药是改善NAFLD患者病情的有希望的疗法。该网络荟萃分析旨在比较和估计益生菌干预措施的相对效果,并确定治疗NAFLD(非酒精性脂肪性肝病)患者的最佳益生菌物种。
    方法:PubMed,WebofScience,Embase,和Cochrane数据库从开始至2024年1月29日进行搜索,以确定以英文发表的RCT.等级框架用于评估有助于每个网络估计的证据质量。
    结果:共35个RCTs,涉及2212个NAFLD患者纳入分析。对于主要结果,乳杆菌+双歧杆菌+链球菌在增强可接受性和降低AST方面表现出最高概率是最好的益生菌组合(SMD:-1.9595%CI:-2.90,-0.99),ALT(SMD=-1.67,95%CI:-2.48,-0.85),和GGT水平(SMD=-2.17,95%CI:-3.27,-1.06)。就次要结果而言,乳杆菌+双歧杆菌+链球菌也是降低BMI的最佳益生菌组合(SMD=-0.45,95%CI:-0.86,-0.04),LDL水平(SMD=-0.45,95%CI:-0.87,-0.02),TC水平(SMD=-1.09,95%CI:-1.89,-0.29),和TNF-α水平(SMD=-1.73,95%CI:-2.72,-0.74)。
    结论:这项网络荟萃分析显示,乳杆菌+双歧杆菌+链球菌可能是治疗肝酶最有效的益生菌组合,脂质分布,和炎症因素。这些发现可用于指导基于益生菌的NAFLD治疗指南的开发,因为不同疗法之间几乎没有直接比较。
    BACKGROUND: Probiotic administration is a promising therapy for improving conditions in NAFLD patients. This network meta-analysis aimed to compare and estimate the relative effects of probiotic interventions and identify the optimal probiotic species for the treatment of NAFLD (Nonalcoholic fatty liver disease) patients.
    METHODS: The PubMed, Web of Science, Embase, and Cochrane databases were searched from inception to 29 January 2024 to identify RCTs that were published in English. The GRADE framework was used to assess the quality of evidence contributing to each network estimate.
    RESULTS: A total of 35 RCTs involving 2212 NAFLD patients were included in the analysis. For primary outcomes, Lactobacillus + Bifidobacterium + Streptococcus exhibited the highest probability of being the finest probiotic combination in terms of enhancing acceptability as well as reducing AST (SMD: -1.95 95% CI: -2.90, -0.99), ALT (SMD = -1.67, 95% CI: -2.48, -0.85), and GGT levels (SMD = -2.17, 95% CI: -3.27, -1.06). In terms of the secondary outcomes, Lactobacillus + Bifidobacterium + Streptococcus was also the best probiotic combination for reducing BMI (SMD = -0.45, 95% CI: -0.86, -0.04), LDL levels (SMD = -0.45, 95% CI: -0.87, -0.02), TC levels (SMD = -1.09, 95% CI: -1.89, -0.29), and TNF-α levels (SMD = -1.73, 95% CI: -2.72, -0.74).
    CONCLUSIONS: This network meta-analysis revealed that Lactobacillus + Bifidobacterium + Streptococcus may be the most effective probiotic combination for the treatment of liver enzymes, lipid profiles, and inflammation factors. These findings can be used to guide the development of a probiotics-based treatment guideline for NAFLD since there are few direct comparisons between different therapies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:对于全球精神病患者来说,获得高质量的精神医疗保健仍然具有挑战性,包括中国。基于智能手机的症状监测有可能支持可扩展的心理健康。然而,没有这样的工具,直到现在,已经为中国的精神病患者开发和评估。这项研究调查了使用专门为中国精神病患者开发的症状自我监测智能手机应用程序(YouXin)的可接受性和经验。
    方法:对10名精神病患者进行半结构化访谈,探讨优心的可接受性。参与者是从测试有效性的非随机可行性研究中招募的,可行性,优信app的可接受性和安全性。数据分析以可接受性理论框架为指导。
    结果:大多数参与者认为该应用程序可以接受且易于使用,没有报告难以承受的负担或机会成本。参与者发现完成自我监控应用程序是有益的,并获得了成就感。隐私和数据安全不是参与者的主要关注点,很大程度上是由于对他们围绕数据保护的治疗医院的信任。参与者发现该应用程序易于使用,并将其归因于研究开始时提供的培训。一些参与者表示,他们已经与该应用程序建立了某种形式的关系,并且在研究完成时会错过该应用程序。
    结论:在中国有精神病经历的人的症状自我监测中,优信应用是可以接受的。参与者通过使用YouXin应用程序获得了有关其症状的更多见解。由于我们在这项研究中只收集了回顾性可接受性,未来的研究有必要在研究开始前评估假设的可接受性,以便更全面地了解实施情况.
    BACKGROUND: Access to high-quality mental healthcare remains challenging for people with psychosis globally, including China. Smartphone-based symptom monitoring has the potential to support scalable mental healthcare. However, no such tool, until now, has been developed and evaluated for people with psychosis in China. This study investigated the acceptability and the experience of using a symptom self-monitoring smartphone app (YouXin) specifically developed for people with psychosis in China.
    METHODS: Semi-structured interviews were conducted with 10 participants with psychosis to explore the acceptability of YouXin. Participants were recruited from the non-randomised feasibility study that tested the validity, feasibility, acceptability and safety of the YouXin app. Data analysis was guided by the theoretical framework of acceptability.
    RESULTS: Most participants felt the app was acceptable and easy to use, and no unbearable burdens or opportunity costs were reported. Participants found completing the self-monitoring app rewarding and experienced a sense of achievement. Privacy and data security were not major concerns for participants, largely due to trust in their treating hospital around data protection. Participants found the app easy to use and attributed this to the training provided at the beginning of the study. A few participants said they had built some form of relationship with the app and would miss the app when the study finished.
    CONCLUSIONS: The YouXin app is acceptable for symptom self-monitoring in people with experience of psychosis in China. Participants gained greater insights about their symptoms by using the YouXin app. As we only collected retrospective acceptability in this study, future studies are warranted to assess hypothetical acceptability before the commencement of study to provide a more comprehensive understanding of implementation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    纤维肌痛对患者的健康和福祉造成了沉重负担,然而,这种情况的有效治疗选择仍然有限。最近,迷走神经刺激(VNS)已成为一种有前途的治疗纤维肌痛。尽管如此,尽管随机临床试验(RCTs)的数量不断增加,目前的证据仍然没有定论。因此,本方案的系统评价和荟萃分析旨在综合现有证据,阐明VNS治疗纤维肌痛的疗效和可接受性.
    将在9个书目数据库中全面搜索符合条件的RCT,即PubMed,科克伦图书馆,Embase,AMED,PsycINFO,PEDro,中国生物医学文献数据库,中国国家知识基础设施,和王方数据库。从纳入的研究中获得的数据将使用RevMan5.4.1进行荟萃分析进行定量合成。纳入随机对照试验的方法学合理性将通过Cochrane更新的偏差风险工具(2.0版)进行评估。此外,敏感性分析,出版偏见评估,和亚组分析将酌情进行。最后,我们将利用建议的分级,评估,发展,和评估(等级)系统来评估证据体的确定性。
    我们的研究结果有望确定VNS作为纤维肌痛的有希望的治疗选择的有效性和可接受性。这不仅可以填补当前的研究空白,还可以确定未来研究的潜在领域。这些发现将为纤维肌痛的循证治疗决策提供必要的指导。有利于患者和临床医生。
    UNASSIGNED: Fibromyalgia has imposed substantial burdens on patients\' health and well-being, yet effective therapeutic options for this condition remain limited. Recently, vagus nerve stimulation (VNS) has emerged as a promising therapy for fibromyalgia. Nonetheless, despite the increasing number of randomized clinical trials (RCTs), current evidence remains inconclusive. Therefore, this protocol of a systematic review and meta-analysis aims to synthesize the existing evidence to clarify the efficacy and acceptability of VNS for treating fibromyalgia.
    UNASSIGNED: A comprehensive search for eligible RCTs will be conducted across nine bibliographic databases, namely PubMed, Cochrane Library, Embase, AMED, PsycINFO, PEDro, Chinese BioMedical Literature Database, Chinese National Knowledge Infrastructure, and Wangfang database. Data obtained from the included studies will be synthesized quantitively using RevMan 5.4.1 for meta-analyses. The methodological soundness of included RCTs will be assessed via the Cochrane\'s updated risk of bias tool (version 2.0). Additionally, sensitivity analyses, publication bias assessment, and subgroup analyses will be conducted as appropriate. Finally, we will utilize the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to evaluate the certainty for the body of evidence.
    UNASSIGNED: The findings of our study are anticipated to ascertain the efficacy and acceptability of VNS as a promising treatment option for fibromyalgia. This will not only fill current research gap but also identify potential areas for future research. The findings will provide essential guidance for evidence-based treatment decisions for fibromyalgia, benefiting both patients and clinicians.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:液态和半固态食物中的NaCl摄入量过多(例如,汤,火锅基地,酱汁)对人类健康构成高风险,减少NaCl的摄入量是全球健康的主要问题。
    结果:使用广义标记幅度(gLMS)方法,该研究验证了通过添加油减少钠的可能性。已确定受损接受阈值(CAT)和享乐拒绝阈值(HRT)。gLMS结果表明,含0.36%NaCl和2.29%葵花籽油(SSO)的样品的咸度强度明显高于仅含0.36%NaCl的样品(p<0.05)。CAT和HRT结果表明,添加3.59%的葵花籽油,NaCl含量可以降低到最低0.14%,而不会引起骨肉汤样品中的感觉排斥。定量描述性分析方法用于确定NaCl和油浓度对骨肉汤样品感官属性的影响。此外,它结合享乐主义量表分析了消费者可接受性驱动因素,以优化低盐骨汤产品的配方。值得注意的是,样品E(0.36%NaCl,2.29%的脂肪)不仅具有明显的盐减少作用,NaCl减少20%,也提高了整体的可接受性。
    结论:本研究为餐饮和食品行业设计减盐美食提供了理论指导,包括骨汤和火锅基地。本文受版权保护。保留所有权利。
    BACKGROUND: Excessive NaCl intake in liquid and semi-solid food (e.g. soup, hot pot base, sauce) poses a high risk to human health, and reducing NaCl intake is a major concern for global health.
    RESULTS: Using the generalized Labeled Magnitude Scale (gLMS) method, the study verified the possibility of sodium reduction through oil addition. The compromised acceptance threshold (CAT) and hedonic rejection threshold (HRT) were determined. The gLMS results showed that the saltiness intensity of samples containing 0.36% NaCl and 2.29% sunflower seed oil was significantly higher than that of samples containing only 0.36% NaCl (P < 0.05). CAT and HRT results indicated that by adding 3.59% sunflower oil, the NaCl content could be reduced to a minimum of 0.14% without causing sensory rejection in bone broth samples. The quantitative descriptive analysis method was used to determine the effects of NaCl and oil concentrations on the sensory attributes of bone broth samples. Furthermore, it was used to analyze the consumer acceptability drivers in combination with the hedonic scale to optimize the formulation of reduced-salt bone broth products. Notably, sample E (0.36% NaCl, 2.29% fat) not only had a significant salt reduction effect with a 20% decrease in NaCl, but also had improved overall acceptability.
    CONCLUSIONS: This study provides theoretical guidance for designing salt-reduction cuisine within the catering and food industries, including bone broth and hot pot bases. © 2024 Society of Chemical Industry.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号